Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon-Reference-Cited by-同舟云学术

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon

Published:2013-12-19 Issue:4 Volume:26 Page:193-201
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Paolo A.,Chiarion-Sileni Vanna,Muggiano Antonio,Mandalà Mario,Pimpinelli Nicola,Vecchio Michele Del,Rinaldi Gaetana,Simeone Ester,Queirolo Paola

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference46 articles.

1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

3. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

4. Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation

5. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phytochemicals as Immunomodulatory Agents in Melanoma;International Journal of Molecular Sciences;2023-01-31

2. Melatonin prevented depressive-like behavior following cyclosporine A or interferon-α administration in mice;Hacettepe University Journal of the Faculty of Pharmacy;2022-09-04

3. Vanillic Acid Prevents Interferon-alpha and Cyclosporine A-induced Depressant-like Behavior in Mice;Journal of Reports in Pharmaceutical Sciences;2022-01

4. Topical Chemotherapy for Ocular Surface Squamous Neoplasia;Global Perspectives in Ocular Oncology;2022

5. Malignant Melanoma: From Molecular Characterization to Targeted Therapies;Reference Module in Biomedical Sciences;2021